| Dr Bruce D Bullock, MD | |
|
8 Commons St, Rutland, VT 05701-4651 | |
| (802) 770-1805 | |
| (802) 773-4876 |
| Full Name | Dr Bruce D Bullock |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 8 Commons St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649250358 | NPI | - | NPPES |
| OVN0388 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0420008555 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna & Hospice Of The Southwest Region Inc | Rutland, VT | Home health agency |
| Bayada Home Health Care | Williston, VT | Home health agency |
| Rutland Area Visiting Nurse Association & Hospice, | Bennington, VT | Hospice |
| Bayada Hospice | Norwich, VT | Hospice |
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Entity Name | Bruce D Bullock Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497271886 PECOS PAC ID: 8628341245 Enrollment ID: O20170901002530 |
News Archive
Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world's most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics.
Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
A Phase III clinical trial at New York University is investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT) using the Sonablate(R) 500.
› Verified 3 days ago
| Entity Name | Marble Valley Healthworks Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801394895 PECOS PAC ID: 2264778638 Enrollment ID: O20190107003076 |
News Archive
Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world's most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics.
Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
A Phase III clinical trial at New York University is investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT) using the Sonablate(R) 500.
› Verified 3 days ago
| Entity Name | True Care Vermont, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073261350 PECOS PAC ID: 2466849955 Enrollment ID: O20220502002083 |
News Archive
Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world's most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics.
Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
A Phase III clinical trial at New York University is investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT) using the Sonablate(R) 500.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce D Bullock, MD 8 Commons St, Rutland, VT 05701-4651 Ph: (802) 770-1805 | Dr Bruce D Bullock, MD 8 Commons St, Rutland, VT 05701-4651 Ph: (802) 770-1805 |
News Archive
Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world's most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics.
Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
A Phase III clinical trial at New York University is investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT) using the Sonablate(R) 500.
› Verified 3 days ago
Richard Carleton Baker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. David Benjamin Turner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Allen St, Suite 403, Rutland, VT 05701 Phone: 802-772-4414 Fax: 802-772-7973 | |
Lisa Hogenkamp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Commons St, Rutland, VT 05701 Phone: 802-747-3359 Fax: 802-786-5204 | |
Frederick Hesse, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 199 Stratton Rd Ste 1, Rutland, VT 05701 Phone: 802-775-7798 Fax: 802-775-7762 | |
Susan E Blish, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-747-6260 | |
Dr. Megan Dawn Wright, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 |